60 Emerging Medical Technology Startups Present to Audience of Investors and Strategics as they Aim to Disrupt the $600B Global Medical Device & Diagnostic Market

Posted by Life Science Intelligence on Jun 4, 2019 7:52:17 AM
Find me on:

The Emerging Medtech Summit 2020 will spotlight Sixty (60) of the hottest emerging medtech companies, many of which are raising capital, ripe for M&A, or already planning for an IPO or exit.

The event will be held February 18-20, 2020 at The Ritz-Carlton Laguna Niguel in Dana Point CA and is already drawing attendance from many of the top strategics and investors, including traditional VCs, angels and alternative financing vehicles.

Emerging MedTech Summit Ritz Carlton

So far half of the presenting companies have been selected and confirmed by LSI. LSI continues to review applications and seek out new companies to be added to the program.

The current roster of innovators includes a mix of seasoned entrepreneurs including industry legends such as Manny Villafana (Medical 21), Jim Corbett (CathWorks), and Bill Hunter (Canary Medical) along with several other proven industry veterans, and fresh entrepreneurs. The current roster of presenting companies includes: Activ Surgical, Auctus Surgical, Avisi Technologies, Canary Medical, CathWorks, Consensus Orthopedics, DiFusion Technologies, Embody, Exact Imaging, Fist Assist, HAPPE Spine, LifeWave Biomedical, LightIntegra Technology, Medical 21, NERv Technologies, NeuEsse, NuCryo Vascular, Previvo, Pristine Surgical, Promaxo, Sana Health, Sense Diagnostics, Shoulder Innovations, VerteCore and ZKR Orthopedics. Additional companies are being added to the agenda regularly.

Keynote Presentation

The Emerging Medtech Summit will be kicked off with a Keynote Presentation titled “The Next Quantum Leaps in Medtech.” It will delivered by industry veteran Christopher Velis, founder of Auris Health and Miraki Innovation. Chris will share his insights on a repeatable process for quantum leaps of innovation. Chris co-founded Auris Health which was acquired by Johnson & Johnson for a total of $5.75 billion in early 2019, and is noted as the the largest medtech venture funded transaction in history.

 

Topics: Startup, Strategics, Medtech, Medtech Venture Capital

Stay connected with our latest posts:

About the Author

Life Science Intelligence (LSI) helps medtech executives make better strategic decisions by delivering unique market data and business insights. For over 13 years LSI has been working with industry giants – Johnson & Johnson, Medtronic, Abbott, Stryker, Cardinal, Boston Scientific, and Becton Dickinson, among others. LSI products are also leveraged by the most successful start-ups, innovators, investors, and service companies that compete in medtech. LSI is the organizer of The Emerging Medtech Summit held annually in Southern California.

Contact LSI here, via phone 714 847 3540, or email info@lsintel.com